Delivery Order SPE2DX22D0099-SPE2D826FAB9Y
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $316,010.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 6, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $16,589.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 4, 2025, with completion scheduled for November 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,173.44 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed-price, non-set-aside contract with performance to be executed in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,173.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 20, 2025, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle running through December 2026 that serves as the company's primary vehicle...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,087.35 firm fixed price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 23, 2025, with an ultimate completion date of October 24, 2025. This non-competitive delivery order, executed at the vendor's corporate office location in Conshohocken, Pennsylvania, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement. As a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $114,336.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 10, 2025, with completion targeted for November 12, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,666.17 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply delivery to support federal healthcare requirements. The contract is performed from AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,387.32 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $47,051.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 27, 2025, with an ultimate completion date of October 28, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAB9YDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $14,013.99 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, classified as a non-set-aside competitive award, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger pharmaceutical supply agreement with the DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a global pharmaceutical support vehicle enabling the company to fulfill medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The contract award demonstrates AmerisourceBergen's continued capability to meet competitive federal procurement requirements and support critical military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 11/10/25 |